[Hot Stock] L&K Bio Rises Intraday on News of New Product Export to the US

[Asia Economy Reporter Ji Yeon-jin] L&K Bio announced yesterday that its new product ‘PassLock-TM,’ approved by the U.S. Food and Drug Administration (FDA) in March this year, has been exported to the United States for the first time through its newly established U.S. subsidiary, L&K Spine.

PassLock-TM is a posterior and posterolateral implant product with the highest frequency of procedures. Like the expandable spinal implant, the Expandable Cage, it allows height adjustment at various widths and angles up to 20 degrees.

PassLock-TM minimizes the incision area during surgery, reducing risks such as excessive bleeding and infection. It helps patients return to daily life in a short time after surgery.